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Introduction
The phosphatase inhibitor vanadate has insulin-like effects and corrects hyperglycemia in insulin-dependent and insulin-independent animal models of diabetes (1, 2) . For these reasons, vanadate administration has been advocated as a therapeutic modality for diabetes. Vanadate has multiple biologic effects, including inhibition of (Na+K+)-ATPase and protein tyrosine phosphatases (PTPases).' Inhibition of tyrosine phosphatases is thought to represent one major mechanism by which vanadate mediates some of its biologic effects, including enhancement of insulin sensitivity (3) . Renal and specifically glomerular injury is a major early feature of diabetic nephropathy. It is manifested as basement membrane thickening and expansion of the glomerular mesangium. This expansion consists primarily of matrix, but hypercellularity and hypertrophy of mesangial cells have recently been reported (4, 5) . There is also increasing evidence that activation of mesangial cells plays a key role not only in diabetes, but also in other forms of acute and chronic glomerular injury in man as well as experimental animals (6) .
The biologic effects of vanadate are very diverse, depending on the target cell and the concentration of vanadate. For example, vanadate induces angiogenesis and mitogenesis in some mesenchymal cells (7) (8) (9) (10) , reverses differentiation of muscle cells mimicking fibroblast growth factor (11 ) , prevents cell death of mouse embryo cells caused by growth factor deprivation ( 12) , and stimulates hyaluronan synthesis in human mesothelial cells (13) . Vanadate has been shown to activate certain signal transduction mechanisms. Since many of the signals that result in mesangial cell activation involve tyrosine phosphorylation, mesangial cells represent a potentially important target for vanadate. There are no data available that address the effect of vanadate on mesangial cells. In this study we explored the biologic effects of vanadate on mesangial cells and show that at low concentrations that inhibit PTPases, vanadate is a strong mitogen for human glomerular mesangial cells and induces PDGF B chain gene expression. This effect of vanadate was associated with enhanced tyrosine phosphorylation and sustained activation of phospholipase C (PLC) and protein kinase C (PKC). Furthermore, DNA synthesis induced by vanadate is dependent on tyrosine phosphorylation and PKC activation. Our in vitro findings may have major implications relevant to the use of vanadate in vivo in the diabetic state.
Methods
Materials. Tissue culture materials were obtained from Gibco (Grand Island, NY). Anti-phosphotyrosine antibody (IgG2bk) was purchased from UBI (Lake Placid, NY). Reagents for PKC assay were purchased as a kit from BRL (Grand Island, NY). Phorbol 12-myristate 13 (15) , whereas the benziquinonoid antibiotic herbimycin is thought to inhibit protein tyrosine kinase (PTK) activity through benziquinone interaction with protein sulfhydral groups ( 16). Quiescent cells were pretreated with the inhibitors before the addition of vanadate.
Autoradiography. The effect of vanadate on DNA synthesis was also determined by autoradiography of labeled nuclei as described (17) . Mesangial cells were plated onto slides (Lab-Tek, Nunc, Inc., Naperville, IL) at a density of 1 x I04 cells per chamber in Waymouth's medium containing 17% FBS. Confluent cells were made quiescent by replacing the culture medium with serum-free medium for 48 h. Vanadate was added for 24 h followed by pulsing for 4 h with 1 'UCi/ml [3H] thymidine. At the end of the pulsing period, an equal volume of freshly prepared 3:1 methanol/acetic acid fixative was added to the medium for 10 min. This half-strength solution was then replaced by an equal volume of undiluted 3:1 methanol/acetic acid fixative. After 10 min, cells were air dried and exposed to nuclear emulsion (NTB = 2, Eastman Kodak Co., Rochester, NY) for 3 d at 4°C. The slides were then developed (Kodak D-19 developer), fixed (Kodak fixer), and stained with hematoxylin/eosin. The number of positive nuclei per microscopic field (x 100) was determined by examining 10-20 fields per slide.
Cell counts. Cells were plated in 12-well dishes at subconfluent density in Waymouth's medium containing FBS. After cell attachment overnight, cells were washed with PBS and incubated with vanadate in serum-free medium. After 2 d, the cultures were washed with PBS and harvested into 1 ml of 0.05% trypsin-EDTA diluted in HBSS without calcium or magnesium. Cells were then resuspended in 1 ml of complete medium containing 17% FBS to neutralize the trypsin and counted using a coulter counter (Coulter Electronics, Hialeah, FL).
RNA isolation and analysis by solution hybridization. Mesangial cells were harvested in guanidine thiocyanate buffer, and RNA was prepared on a cesium chloride gradient. Total RNA was quantitated by optical density, and integrity was confirmed by ethidium bromide staining of ribosomal RNA. A ribonuclease protection assay was used to determine PDGF B chain expression using a procedure described earlier ( 18) . The DNA template was constructed by cloning a 960-bp BanTIBanI restriction fragment, encompassing portions of exons 6 and 7 of the c-sis gene, into the SmaI site of plasmid pT7-2 (United States Biochemical Corp., Cleveland, OH). To generate the single-stranded 32P-labeled RNA probe, the plasmid was linearized and transcription was performed using the T7 RNA polymerase (Promega, Madison, WI) in the presence of 40 mM Tris-HCl, pH 7.5, 6 mM MgCl2, 10 mM NaCl, 2 mM spermidine, 40 mM DTT, 40 U/ml RNasin, 0.5 mM each of ATP, GTP, and CTP, 12 jiM UTP, 50 ,uCi of [32P]UTP (800 Ci/ mmol; Amersham, Arlington Heights, IL) at 37°C for 1 h. This was followed by the addition of RNase-free DNase (Promega) and another 15-min incubation to remove any remaining DNA template. After repeated extraction with phenol/chloroform and precipitation in ethanol, the RNA pellet was resuspended in hybridization buffer consisting of 80% formamide. The labeled RNA probe (106 cpm) was hybridized overnight at 55°C to 100 jig of total RNA prepared from mesangial cells. After hybridization, the samples were digested with RNase A (50 ,ig/ml) and RNase TI (2 jig/ml) followed by the addition of proteinase K to inactivate the remaining RNase. After extraction in phenol/chloroform, the samples were precipitated twice in ethanol, redissolved in loading buffer containing 90% formamide, and separated on 6% polyacrylamide/urea gel. Gels were exposed to x-ray film (X-Omat, Kodak) with intensifying screens at -70°C.
Labeling of substrates and assay of PTPase activity. Myelin basic protein (MBP) and reduced carboxymethylated and maleylated lysozyme (RCML) (Sigma Chemical Co.) were labeled on tyrosine residues using [y-32P]ATP (Du-Pont-New England Nuclear, Boston, MA) and p603-src tyrosine kinase (Oncogene Science, Manhasset, NY) as described (19). 5 jg of MBP or RCML was incubated at 300C for 30 min with 2 U of p60c-s and 20 jiCi of [y-32P]ATP in 50 mM Hepes, pH 7.4, 10 mM MnCl2 buffer. The reaction was terminated by adding 0.12 ml of 10% phosphoric acid, 0.5 ml of 20% (wt/vol) TCA, 20 mM NaH2PO4, and 0.04 ml of 5 mg/ml BSA. After incubation on ice for 30 min, the reaction mixture was centrifuged at 10,000 g for 3 min.
The protein precipitates were washed three times with 20% (wt/vol) TCA, 20 mM NaH2PO4 and then dissolved in 0.2 M Tris-HCl, pH 8.0. After vanadate stimulation, quiescent mesangial cells were washed twice with ice-cold PBS, homogenized in a lysis buffer (250 mM sucrose, 5 mM EDTA, 50 mM Hepes, pH 7.4,5 mM benzamidine, 115 jM PMSF, 0.05% aprotinin, 1% Triton X-100), and centrifuged for 30 min at 4°C at 10,000 g. The supernatant was stored frozen at -700C until assay. For phosphatase assay, 0.5 jg of total cell lysate was assayed for PTPase activity in a total volume of 50 Il containing 5 jil of phosphatase buffer (25 mM Hepes, pH 7.3, 5 mM EDTA, 10 mM DTT) in the presence of tyrosine-phosphorylated MBP or RCML (2-4 x 104 cpm). The reaction mixture was incubated at 300C for 30 min, and 0.75 ml of charcoal acidic mixture (0.9 M HCl, 2 mM NaH2PO4, 4% [wt/vol] Norit A; Sigma Chemical Co.) was added to terminate the reaction. After centrifugation for 10 min at 10,000 g, the free radioactivity in 0.4 ml of supernatant was measured. Enzyme activity was expressed as a percentage of radioactivity released from the total phosphorylated substrate. Each sample was run in duplicate.
Westem blot analysis. Quiescent cells were incubated with 7.5 jM vanadate for 30 min. The cells were then washed three times with icecold PBS and lysed in solubilization buffer (20 mM Tris-HCI, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 1 mM Na3VO4, 1 mM PMSF, 0.25% aprotinin) at 40C for 30 min. The soluble cell extract was centrifuged at 10,000 g for 30 min. Protein concentration was determined by a protein reagent assay (Bio-Rad Laboratories, Richmond, CA). Equal amounts of untreated and vanadate-treated cell lysates were analyzed on 7.5%-SDS gel. Separated proteins were transferred to nitrocellulose and immunoblotted with anti-phosphotyrosine mAb. The bound antibody was detected by 251I-protein A (20) .
Analysis of inositol phosphates. Inositol phosphates were measured as described (21) . Confluent mesangial cells in six-well dishes were placed in inositol-free, serum-free RPMI 1640 medium containing 3 jiCi/ml 2 [3H] myoinositol (Amersham) for 48 h. After a 15-min preincubation with 15 mM LiCl at 370C, vanadate was added for different time periods. The incubation was terminated by quickly aspirating the medium and adding 2 ml of ice-cold 5% TCA. The cells were then Vanadate and Mesangial Cells scraped, and each well was rinsed with another 2 ml of 5% TCA. The TCA was then removed by extracting the sample twice with diethyl ether. The samples were neutralized and loaded onto 2-ml anion exchange columns (AGIX8, Bio-Rad Laboratories). The columns were washed with 10 ml of water and 10 ml of 5 mM sodium tetraborate. Inositol phosphates were then eluted with 10 ml of increasing concentration of ammonium formate in 0.1 M formic acid. Using this technique, ammonium inositol 1,4,5-trisphosphate (1P3) elutes with 0.8 M ammonium formate. 5 ml of each collected fraction was mixed with scintillation fluid and counted in a beta counter.
Intracellular calcium measurement. Intracellular calcium was measured as described previously (21) . Mesangial cells were plated onto 14 x 14 mm plastic coverslips (Aclar, Proplastics, Linden, NY), placed in 12-well dishes, and grown in Waymouth's medium containing serum. Confluent cells were washed and placed in serum-free Waymouth's medium containing 0.2% BSA for 18 h. The cells were loaded with fura-2 by incubation for 50 min at 37°C in 1 ml of serum-free medium containing 0.2% BSA, 5 aM fura-2 acetoxymethylester (Molecular Probes, Eugene, OR), and 0.02% pluronic acid F127 (Molecular Probes). At the end of the loading period, the coverslips were washed with physiological salt solution (150 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 10 mM Hepes, 10 mM glucose) containing 0.2% BSA and kept in the same solution on ice until use; the cells were used within 2 h of loading. Coverslips were rapidly rinsed in physiological salt solution to remove any residual leaked dye and then placed diagonally in a square quartz cuvette so that the excitation and emission paths were at 450 angles to the coverslip. The cuvette, containing 2.5 ml of physiological salt solution, with its stirring device was placed in a thermostatically controlled chamber at 37°C in the Deltascan system I (PTI, New Brunswick, NJ). A 450-W xenon lamp was used as a light source. Excitation wavelengths were 340 and 380 nm, and emitted light was collected at 510 nm. Integration time was 0.1 s at each wavelength. Readings were collected using Delta-scan software (PTI). The 340/380 ratio was then processed as previously described (22) to determine the intracellular free calcium concentration. The Kd for fura 2 was assumed to be 224 nM. For each monolayer, the maximal fluorescence ratio was determined by lysing the cells with 0.5% Triton X-100, and the minimal fluorescence ratio was determined by the addition of 10 mM EGTA.
PKC assay. PKC assay was performed as previously described by us (23) . Confluent mesangial cells were made quiescent by placing them in serum-free medium for 48 h. Cells were incubated with 7.5 ,uM vanadate for 15 min. The cells were washed twice with PBS and lysed in homogenization buffer (20 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 0.5% Triton X-100, 25 Mg/ml aprotinin, 25 ,ug/ml leupeptin) at 4°C. The cell lysate was centrifuged at 10,000 g for 30 min at 4°C. PKC was partially purified using the DE-52 (DEAE) column. The protein concentration in the eluate was measured by the BioRad method. PKC activity was determined as described (24, 25) (Fig. 1 a) (Fig. 1 b) . (Fig. 2 a) . When tyrosine-phosphorylated MBP was used as substrate, PTPase activity was inhibited at concentrations as low as 1 ,uM vanadate and a significant inhibition was observed at 10 MM (Fig. 2 b) . Treatment (Fig. 3) . Involvement of tyrosine phosphorylation in vanadate-induced cell proliferation. Activation of tyrosine kinases by vanadate has been shown in other cell types (26, 27) (Fig. 4, a and b) ; 0.025% DMSO vehicle had no effect on DNA synthesis. These results indicate that increase in 1P3 production, which was detected with a peak effect at 30 min (Fig. 6 ). This response Of 1P3 iS similar to the 1P3 response of certain growth factors with tyrosine kinase receptors (29, 30) . To test the functional significance of this 1P3 production, we next studied the effect of vanadate on intracellular calcium release in mesangial cells. Fig. 7 (18, 23) .
PMA also stimulates DNA synthesis in these cells (18) . To determine whether PKC activation is necessary for vanadateinduced mitogenesis, we studied the effect of downregulation of PKC on vanadate-induced DNA synthesis. Mesangial cells were chronically treated with PMA to downregulate PKC. Completeness of downregulation was tested by studying PMA-induced PKC activity (Fig. 8) and DNA synthesis, both of which were abrogated after PMA pretreatment. As shown in Fig. 9 , 
Discussion
Vanadate has insulinomimetic effects in vitro in isolated adipocytes and in vivo in animal models of diabetes. In streptozotocin-treated diabetic rats and in mouse models of non-insulindependent diabetes mellitus, treatment with vanadate has a beneficial effect, resulting in reduction of blood glucose levels and correction of several of the metabolic abnormalities (1, 2) . These studies prompted the evaluation of vanadate as a therapeutic adjunct to insulin for the treatment of diabetes mellitus in humans (31, 32) . The mechanism by which vanadate is thought to potentiate the effect of insulin is not precisely known. However, inhibition of tyrosine phosphatases that dephosphorylate the insulin receptor substrate and sustain its biologic activity is thought to be the major underlying mechanism. Inhibition of PTPases by vanadate has been recognized as positive and negative regulator of signal transduction (33) (34) (35) . Therefore, vana- Figure 5 . Time course for the effect of vanadate on PDGF B chain mRNA. Confluent cells were made quiescent in serum-free medium before exposure to vanadate. At the times indicated, cells were harvested and RNA was isolated. 100 jig of total RNA or control transfer RNA was hybridized with an in vitro-transcribed labeled RNA. After digestion with RNase A and TI, protected fragments were electrophoresed on a denaturating polyacrylamide gel and detected by autoradiography. Bands shown of 300 and 150 nucleotides correspond to those portions of the sixth and seventh exons of the c-sis probe that were protected from RNase digestion. Stimulation was also observed in two other experiments. date may exert its biologic effect in a cell-or tissue-specific manner. Nephropathy, a major complication of diabetes mellitus, is characterized by mesangial cell activation with development of mesangial matrix expansion, mesangial cell hypertrophy, and proliferation (4, 5) . Since vanadate administered in vivo is concentrated in the kidney (32, 36) (41, 42) . Although extrapolation from in vitro to in vivo studies should be cautious, our data may have implications relevant to the use of vanadate as a therapeutic modality for diabetes. Activation of mesangial cells with subsequent proliferation and matrix expansion leads to glomerular impairment and eventual fibrosis (43, 44) . Induction of PDGF B chain may be responsible for phenotypic changes in mesangial cells in the diabetic microenvironment. Besides its mitogenic activity, PDGF may mediate collagen synthesis induced by glycosylated proteins in mesangial cells (45) . Studies in experimental models of renal injury revealed that cell proliferation occurs with concomitant upregulation of PDGF and its receptors (45) (46) (47) (48) . More recently, increased expression of several cytokines with tyrosine kinase receptors has been demonstrated in isolated glomeruli a few weeks after the induction of diabetes (49) . These cytokines may be responsible for activation of mesangial cells. More importantly, potentiation of the effect of these cytokines by vanadate in vivo may potentially contribute to the progression of glomerular injury. This is particularly important since vanadate in most instances will be administered well after the diabetic state has ensued. Vanadate also activates mesangial cells even when they are maintained in relatively normal glucose concentration, suggesting that potential deleterious effects of vanadate may be detected even when hyperglycemia is controlled. It is important to note that whereas very high concentrations of vanadate (0.5 -1 mM) are required to activate the insulin receptor kinase and to mimic the metabolic effect of insulin, much lower concentrations of vanadate (1-10 ,uM) are sufficient to inhibit PTPase activities, as shown in this study (27, 50) . Our in vitro observations warrant in vivo studies to address further the biologic effect and potential deleterious role of vanadate on the course of diabetic nephropathy.
